Biogen Inc.

Biogen Beats on EPS, Stock Up 1.58%

Biogen's strong EPS performance indicates better-than-expected profitability, which likely contributed to the positive stock reaction of 1.58%. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors may be encouraged by the management's focus on their pipeline, but will be looking for more detailed financial projections in future reports.